Cognitive forms of multiple sclerosis: report of a dementia case

Souraya Stoquart-Elsankari1, Bertille Périn, Pierre Lehmann

  • 1Department of Neurology, Amiens University Hospital, 80054 Amiens Cedex, France. sorayaelsankari560@hotmail.com <sorayaelsankari560@hotmail.com>

Insights

Cognitive impairment is a known issue in multiple sclerosis (MS). This case study highlights a severe cognitive presentation at MS onset, emphasizing the need to consider cognitive decline in MS diagnosis and management.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Background:

  • Cognitive impairment is increasingly recognized in multiple sclerosis (MS).
  • Published case series have documented MS patients with primary cognitive deficits.
  • Understanding the spectrum of MS cognitive presentations is crucial for diagnosis.

Observation:

  • A female patient presented with severe cognitive impairment at the initial onset of multiple sclerosis (MS).
  • The patient experienced a rapidly progressing, demented clinical course.
  • Magnetic Resonance Imaging (MRI) results were analyzed to correlate with cognitive decline.

Findings:

  • The case illustrates a severe, dementia-like cognitive presentation at the onset of MS.
  • MRI findings in this patient are presented in the context of cognitive symptoms.
  • This observation adds to the literature on primary cognitive MS subtypes.

Implications:

  • This case underscores the importance of early cognitive assessment in MS diagnosis.
  • Recognizing severe cognitive onset in MS can guide treatment strategies.
  • Further research into primary cognitive MS variants is warranted to improve patient outcomes.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...